rivaroxaban

Generic: rivaroxaban

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivaroxaban
Generic Name rivaroxaban
Labeler ascend laboratories, llc
Dosage Form GRANULE, FOR SUSPENSION
Routes
ORAL
Active Ingredients

rivaroxaban 155 mg/1

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-882
Product ID 67877-882_d111f8d6-a073-4a43-bf16-bc1bacba9898
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218502
Listing Expiration 2026-12-31
Marketing Start 2025-07-07

Pharmacologic Class

Established (EPC)
factor xa inhibitor [epc]
Mechanism of Action
factor xa inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877882
Hyphenated Format 67877-882

Supplemental Identifiers

RxCUI
2588062
UPC
0367877882710
UNII
9NDF7JZ4M3
NUI
N0000175635 N0000175637

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivaroxaban (source: ndc)
Generic Name rivaroxaban (source: ndc)
Application Number ANDA218502 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 155 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE
source: ndc

Packages (1)

67877-882-71 1 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

Ingredients (1)

rivaroxaban (155 mg/1)

Linked Drug Pages (1)

Rivaroxaban ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d111f8d6-a073-4a43-bf16-bc1bacba9898", "openfda": {"nui": ["N0000175635", "N0000175637"], "upc": ["0367877882710"], "unii": ["9NDF7JZ4M3"], "rxcui": ["2588062"], "spl_set_id": ["c0efa9f9-ca7a-471a-8030-99056fa5da09"], "pharm_class_epc": ["Factor Xa Inhibitor [EPC]"], "pharm_class_moa": ["Factor Xa Inhibitors [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (67877-882-71)  / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE", "package_ndc": "67877-882-71", "marketing_start_date": "20250707"}], "brand_name": "Rivaroxaban", "product_id": "67877-882_d111f8d6-a073-4a43-bf16-bc1bacba9898", "dosage_form": "GRANULE, FOR SUSPENSION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "67877-882", "generic_name": "Rivaroxaban", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivaroxaban", "active_ingredients": [{"name": "RIVAROXABAN", "strength": "155 mg/1"}], "application_number": "ANDA218502", "marketing_category": "ANDA", "marketing_start_date": "20250707", "listing_expiration_date": "20261231"}